Viguerie Alex, Gopalappa Chaitra, Lyles Cynthia M, Farnham Paul G
Centers for Disease Control and Prevention (CDC), National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Division of HIV Prevention (DHP), Quantitative Sciences Branch (QSB), USA.
Centers for Disease Control and Prevention (CDC), National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Division of HIV Prevention (DHP), Quantitative Sciences Branch (QSB), USA; Department of Mechanical and Industrial Engineering, University of Massachusetts Amherst, Amherst, MA 01003, USA.
Epidemics. 2024 Dec;49:100796. doi: 10.1016/j.epidem.2024.100796. Epub 2024 Oct 5.
The OraQuick In-Home HIV self-test represents a fast, inexpensive, and convenient method for users to assess their HIV status. If integrated thoughtfully into existing testing practices, accompanied by efficient pathways to formal diagnosis, self-testing could enhance both HIV awareness and reduce HIV incidence. However, currently available self-tests are less sensitive, particularly for recent infection, when compared to gold-standard laboratory tests. It is important to understand the impact if some portion of standard testing is replaced by self-tests. We used a compartmental model to evaluate the effects of self-testing in diverse scenarios among gay, bisexual and other men who have sex with men (MSM) in the United States for the period 2020-2030, and to understand which scenarios maximize the advantages of self-testing.
We introduced a novel 4-compartment model for HIV self-testing. We employed the model under different screening rates, self-test proportions, and delays to diagnosis for those identified through self-tests to determine the potential effects of self-testing on HIV incidence and awareness of status when applied to the US MSM population. We studied scenarios in which self-tests supplement laboratory-based tests, with no replacement, and scenarios in which some replacement occurs. We also examined how future improvements in self-test sensitivity may affect our results.
When HIV self-tests are supplemental rather than substitutes for laboratory-based testing, self-testing can decrease HIV incidence among MSM in the US by up to 10 % and increase awareness of status among MSM from 85 % to 91 % over a 10-year period, provided linkage to care and formal diagnosis occur promptly following a positive self-test (90 days or less). As self-tests replace a higher percentage laboratory-based testing algorithms, increases in overall testing rates were necessary to ensure reductions in HIV incidence. However, such needed increases were relatively small (under 10 % for prompt engagement in care and moderate levels of replacement). Improvements in self-test sensitivity and/or decreases in the detection period may further reduce any necessary increases in overall testing by up to 40 %.
If properly utilized, self-testing can provide significant long-term reductions to HIV incidence and improve awareness of HIV status. Ensuring that self-testing increases overall testing and that formal diagnosis and engagement in care occur promptly following a positive self-test are necessary to maximize the benefits of self-testing. Future improvements in self-test sensitivity and reductions in the detection period would further reduce HIV incidence and the potential risks associated with replacing laboratory tests with self-tests.
奥芮思居家HIV自检是一种快速、廉价且便捷的方法,可供用户评估自身的HIV感染状况。如果能经过精心整合融入现有的检测实践,并伴有通向正规诊断的有效途径,自检可提高HIV知晓率并降低HIV发病率。然而,与金标准实验室检测相比,目前可用的自检灵敏度较低,尤其是对于近期感染而言。了解部分标准检测被自检取代所产生的影响很重要。我们使用了一个房室模型来评估2020年至2030年期间在美国男同性恋、双性恋和其他与男性发生性行为者(MSM)中不同场景下HIV自检的效果,并了解哪些场景能使自检的优势最大化。
我们引入了一种用于HIV自检的新型四房室模型。我们在不同的筛查率、自检比例以及通过自检确诊者的诊断延迟情况下应用该模型,以确定自检应用于美国男男性行为人群时对HIV发病率和感染状况知晓率的潜在影响。我们研究了自检补充基于实验室检测(无替代)的场景,以及存在部分替代的场景。我们还研究了未来自检灵敏度的提高可能如何影响我们的结果。
当HIV自检是基于实验室检测的补充而非替代时,在10年期间,自检可使美国男男性行为者中的HIV发病率降低多达10%,并使男男性行为者的感染状况知晓率从85%提高到91%,前提是在自检呈阳性后能迅速(90天或更短时间)获得治疗和正规诊断。随着自检取代基于实验室检测算法的比例增加,有必要提高总体检测率以确保降低HIV发病率。然而,这种所需的增加幅度相对较小(对于及时接受治疗和中等程度的替代而言,增幅低于10%)。自检灵敏度的提高和/或检测期的缩短可能会使总体检测所需的任何必要增加进一步降低多达40%。
如果使用得当,自检可在长期显著降低HIV发病率并提高对HIV感染状况的知晓率。确保自检能增加总体检测量,并在自检呈阳性后能迅速进行正规诊断和接受治疗,对于使自检的益处最大化是必要的。未来自检灵敏度的提高和检测期的缩短将进一步降低HIV发病率以及用自检替代实验室检测相关的潜在风险。